Nutlin-3 promotes HBV replication by activating mTOR-mediated autophagy
BackgroundCurrently, there are approximately 240 million individuals worldwide suffering from chronic hepatitis B infection, yet a definitive cure remains elusive. In the context of pharmaceutical interventions for this patient population, the potential issue of Hepatitis B virus (HBV) reactivation...
| Auteurs principaux: | , , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
Frontiers Media S.A.
2024-11-01
|
| Collection: | Acta Virologica |
| Sujets: | |
| Accès en ligne: | https://www.frontierspartnerships.org/articles/10.3389/av.2024.12585/full |